Certara to Participate in Upcoming Investor Conferences

RADNOR, Pa., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:

• TD Cowen 46
  th
  Annual Health Care Conference
  Date and Time: Tuesday, March 3
  rd
  , 2026, at 3:10PM ET

• Leerink Global Healthcare Conference
  Date and Time: Monday, March 9
  th
  , 2026, at 8:00AM ET

• Barclays 28
  th
  Annual Global Healthcare Conference
  Date and Time: Tuesday, March 10
  th
  , 2026, at 1:00PM ET

Live webcasts for each of the conferences will be available on Certara’s investor relations website and will be available for replay for at least 90 days thereafter.

About Certara
Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,600 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.

Investor Relations Contact:
David Deuchler
Gilmartin Group

Media Contact:
Alyssa Horowitz